Cargando…
Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges
SIMPLE SUMMARY: It is widely believed that cancer is developed due to changes in the genetic codes of our DNA, leading to abnormal growth of cells. In the past few years scientists have discovered a system which is used as an immune mechanism by bacteria in order to cleave the invading viruses, call...
Autores principales: | Rafii, Saeed, Tashkandi, Emad, Bukhari, Nedal, Al-Shamsi, Humaid O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870204/ https://www.ncbi.nlm.nih.gov/pubmed/35205694 http://dx.doi.org/10.3390/cancers14040947 |
Ejemplares similares
-
Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature
por: Bukhari, Nedal, et al.
Publicado: (2021) -
Suggested Modifications to the Management of Patients With Breast Cancer During the COVID-19 Pandemic: Web-Based Survey Study
por: Elsamany, Shereef, et al.
Publicado: (2021) -
Update on the Treatment of Metastatic Urothelial Carcinoma
por: Bukhari, Nedal, et al.
Publicado: (2018) -
Current Status of Management of Hepatocellular Carcinoma in The Gulf Region: Challenges and Recommendations
por: Albarrak, Jasem, et al.
Publicado: (2023) -
CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
por: Lee, Choongho
Publicado: (2019)